| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $69.67B | +7.4% |
| Cost of Revenue | $47.44B | +8.5% |
| R&D Expense | $817.3M | -29.0% |
| SG&A Expense | $4.35B | +1.6% |
| Operating Income | $10.23B | +6.6% |
| Interest Expense | $228.6M | +287.6% |
| Pre-tax Income | $10.27B | +5.9% |
| Income Tax | $2.44B | +6.9% |
| Net Income | $7.68B |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.48B | +129.4% |
| Short-term Investments | $5.9M | +10.2% |
| Accounts Receivable | $13.07B | +10.0% |
| Current Assets | $28.90B | +38.6% |
| Total Assets | $65.39B | +16.9% |
| Current Liabilities | $20.35B | +7.3% |
| Long-term Debt | $5.03B | +6302.5% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.47B | +25.7% |
| Capital Expenditures | $600.0M | +16.2% |
| Investing Cash Flow | -$2.02B | +71.4% |
| Financing Cash Flow | -$2.95B | +51.4% |
| Free Cash Flow | $10.87B | +26.2% |
| +5.7% |
| EPS (Basic) | $12.29 | +6.2% |
| EPS (Diluted) | $12.15 | +6.2% |
| Stockholders' Equity |
| $31.20B |
| +10.3% |